WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013

Nov 6, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-11-05

Reporting Person: GAILEY JOHN R (Sr. VP, Gen. Counsel & Sec.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-05	Common Stock	M	6000.0000	$16.0450	Acquired	61069.2000	Direct
2013-11-05	Common Stock	S	6000.0000	$46.8264	Disposed	55069.2000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-11-05	Stock Option (Right to Buy)	$16.0450	M	6000.0000	Disposed	2019-02-24	Common Stock (6000.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1451.3764	Indirect
Common Stock	20076.1250	Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.